Ghent

Ghent, Belgium, has solidified its status as a premier global life sciences hub, particularly renowned for its world-class biotechnology cluster at Tech Lane Ghent.

As a cornerstone of the Flanders BioRegion, the city is a powerhouse in pharmaceutical R&D, driven by the prestigious VIB (Flanders Institute for Biotechnology) and Ghent University.

The ecosystem excels in biotech, with specialized expertise in antibody therapeutics, inflammation research and CAR-T cell therapy.

In addition to drug development, Ghent is a leader in green biotechnology, hosting one of the world's largest concentrations of plant systems biology research.

The city’s healthcare innovation is bolstered by the Ghent University Hospital (UZ Gent), which facilitates seamless translational research and clinical trials.

Emerging sectors like medtech are supported by initiatives such as MeDTeG, which streamline the path to market for innovative medical devices and digital health solutions.

A robust venture capital environment and a high density of university spin-offs ensure a constant pipeline of biotech startups and life sciences investment opportunities.

Furthermore, the presence of GMP-certified manufacturing units allows for the in-house production of advanced therapies, including lipid nanoparticles.

This integrated approach, combining academic excellence with industrial scale, makes Ghent an essential destination for global life sciences collaboration.